Clinical trial
Natural Killer Cells Reconstitution Kinetics Post T Cells Repleted Haploidentical Transplantation
NCT02978274 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Natural Killer Cells Reconstitution Kinetics Post T Cells Repleted Haploidentical Transplantation
- Lead sponsor
- Peking University People's Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 31, 2015
- Completion date
- December 31, 2022
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
natural killer cell mediated immunity